Rejuveinix Shows a Favorable Clinical Safety Profile in...

Frontiers in Pharmacology 2020 / 11 Vol. 11

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

Uckun, Fatih M., Carlson, James, Orhan, Cemal, Powell, Joy, Pizzimenti, Natalie M., van Wyk, Hendrik, Ozercan, Ibrahim H., Volk, Michael, Sahin, Kazim
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Journal:
Frontiers in Pharmacology
DOI:
10.3389/fphar.2020.594321
Date:
November, 2020
File:
PDF, 3.65 MB
2020
Conversion to is in progress
Conversion to is failed